Genpact Limited (NYSE:G - Get Free Report) has been assigned a consensus rating of "Hold" from the seven analysts that are currently covering the company, MarketBeat reports. Four research analysts have rated the stock with a hold recommendation and three have assigned a buy recommendation to the company. The average 1-year price target among analysts that have updated their coverage on the stock in the last year is $50.71.
A number of analysts have recently issued reports on the company. Needham & Company LLC decreased their target price on Genpact from $55.00 to $50.00 and set a "buy" rating for the company in a report on Thursday, May 8th. Mizuho raised their target price on shares of Genpact from $45.00 to $55.00 and gave the company a "neutral" rating in a research note on Monday, February 10th. TD Cowen upgraded shares of Genpact from a "hold" rating to a "buy" rating and lifted their target price for the company from $45.00 to $60.00 in a report on Friday, February 7th. Finally, Robert W. Baird lowered their price target on Genpact from $56.00 to $50.00 and set a "neutral" rating for the company in a report on Thursday, May 8th.
Read Our Latest Research Report on Genpact
Insider Activity
In related news, CEO Balkrishan Kalra sold 13,600 shares of the firm's stock in a transaction that occurred on Thursday, March 13th. The stock was sold at an average price of $48.89, for a total value of $664,904.00. Following the sale, the chief executive officer now directly owns 310,246 shares in the company, valued at $15,167,926.94. This trade represents a 4.20% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, Director Nicholas C. Gangestad purchased 2,000 shares of the stock in a transaction dated Tuesday, May 13th. The shares were acquired at an average cost of $43.97 per share, for a total transaction of $87,940.00. Following the completion of the acquisition, the director now directly owns 2,000 shares of the company's stock, valued at approximately $87,940. This trade represents a ∞ increase in their position. The disclosure for this purchase can be found here. Company insiders own 3.07% of the company's stock.
Institutional Investors Weigh In On Genpact
A number of institutional investors have recently added to or reduced their stakes in G. Cornerstone Planning Group LLC bought a new stake in Genpact during the first quarter worth approximately $27,000. Coppell Advisory Solutions LLC grew its holdings in shares of Genpact by 529.5% in the 4th quarter. Coppell Advisory Solutions LLC now owns 598 shares of the business services provider's stock worth $25,000 after acquiring an additional 503 shares during the last quarter. SRH Advisors LLC acquired a new stake in shares of Genpact during the fourth quarter worth $26,000. Atlas Capital Advisors Inc. lifted its holdings in shares of Genpact by 55.8% during the fourth quarter. Atlas Capital Advisors Inc. now owns 603 shares of the business services provider's stock valued at $26,000 after purchasing an additional 216 shares during the last quarter. Finally, Richardson Financial Services Inc. acquired a new stake in Genpact during the 1st quarter worth about $35,000. 96.03% of the stock is currently owned by institutional investors and hedge funds.
Genpact Trading Up 2.4%
NYSE G traded up $0.99 during mid-day trading on Friday, reaching $43.09. 1,606,953 shares of the stock were exchanged, compared to its average volume of 1,376,125. The stock has a market capitalization of $7.54 billion, a PE ratio of 15.17, a PEG ratio of 1.84 and a beta of 1.02. The company has a debt-to-equity ratio of 0.50, a quick ratio of 1.85 and a current ratio of 2.16. Genpact has a 1-year low of $30.38 and a 1-year high of $56.76. The business's fifty day simple moving average is $46.13 and its 200 day simple moving average is $47.22.
Genpact (NYSE:G - Get Free Report) last released its earnings results on Wednesday, May 7th. The business services provider reported $0.84 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.80 by $0.04. Genpact had a net margin of 10.77% and a return on equity of 22.50%. The firm had revenue of $1.21 billion during the quarter, compared to the consensus estimate of $1.21 billion. During the same period in the previous year, the firm earned $0.73 earnings per share. Genpact's revenue was up 7.4% compared to the same quarter last year. On average, research analysts anticipate that Genpact will post 3.21 earnings per share for the current fiscal year.
Genpact Announces Dividend
The company also recently announced a quarterly dividend, which will be paid on Monday, June 30th. Shareholders of record on Wednesday, June 18th will be issued a dividend of $0.17 per share. This represents a $0.68 dividend on an annualized basis and a yield of 1.58%. Genpact's dividend payout ratio is presently 23.21%.
Genpact Company Profile
(
Get Free ReportGenpact Limited provides business process outsourcing and information technology services in India, rest of Asia, North and Latin America, and Europe. It operates through three segments: Financial services; Consumer and Healthcare; and High Tech and Manufacturing. The Financial Services segment offers retail customer onboarding, customer service, collections, card servicing operations, loan and payment operations, commercial loan, equipment and auto loan, mortgage origination, compliance services, reporting and monitoring, and wealth management operations support; financial crime and risk management services; and underwriting support, new business processing, policy administration, claims management, catastrophe modeling and actuarial services, as well as property and casualty claims.
Further Reading

Before you consider Genpact, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Genpact wasn't on the list.
While Genpact currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.